Selective COX-2 inhibitors as anticancer agents: a patent review (2018-2023).
Saved in:
| Title: | Selective COX-2 inhibitors as anticancer agents: a patent review (2018-2023). |
|---|---|
| Authors: | Mahboubi-Rabbani M; Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran., Abdolghaffari AH; Department of Toxicology & Pharmacology, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.; GI Pharmacology Interest Group (GPIG), Universal Scientific Education and Research Network (USERN), Tehran, Iran., Ghesmati M; Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran., Amini A; Department of Medicinal Chemistry, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Zarghi A; Department of Medicinal Chemistry, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran. |
| Source: | Expert opinion on therapeutic patents [Expert Opin Ther Pat] 2024 Sep; Vol. 34 (9), pp. 733-757. Date of Electronic Publication: 2024 Jul 03. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Informa Healthcare Country of Publication: England NLM ID: 9516419 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7674 (Electronic) Linking ISSN: 13543776 NLM ISO Abbreviation: Expert Opin Ther Pat Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1744-7674 |
|---|---|
| DOI: | 10.1080/13543776.2024.2373771 |
